Connection

JENNIFER FOSTER to Retrospective Studies

This is a "connection" page, showing publications JENNIFER FOSTER has written about Retrospective Studies.
Connection Strength

0.441
  1. The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single-center experience. Pediatr Blood Cancer. 2024 Nov; 71(11):e31214.
    View in: PubMed
    Score: 0.067
  2. Investigating Potential Drug-Drug Interactions in Pediatric and Adolescent Patients Receiving Chemotherapy. J Oncol Pharm Pract. 2022 Jun; 28(4):904-909.
    View in: PubMed
    Score: 0.056
  3. Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage. Pediatr Blood Cancer. 2020 09; 67(9):e28334.
    View in: PubMed
    Score: 0.050
  4. Risk factors associated with delayed methotrexate clearance and increased toxicity in pediatric patients with osteosarcoma. Pediatr Blood Cancer. 2020 04; 67(4):e28123.
    View in: PubMed
    Score: 0.048
  5. Immunoglobulin prophylaxis in pediatric hematopoietic stem cell transplant. Pediatr Blood Cancer. 2018 12; 65(12):e27348.
    View in: PubMed
    Score: 0.044
  6. Using a Bedside Algorithm to Individually Dose High-dose Methotrexate for Patients at Risk for Toxicity. J Pediatr Hematol Oncol. 2017 01; 39(1):72-76.
    View in: PubMed
    Score: 0.039
  7. Minimal residual disease detected prior to hematopoietic cell transplantation. Pediatr Blood Cancer. 2011 Jul 15; 57(1):163-5.
    View in: PubMed
    Score: 0.026
  8. Indications and Outcomes for Tracheostomies in Pediatric Oncology Patients-A Single Center Study. Pediatr Blood Cancer. 2025 Feb; 72(2):e31451.
    View in: PubMed
    Score: 0.017
  9. Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor. J Clin Oncol. 2023 01 20; 41(3):508-516.
    View in: PubMed
    Score: 0.015
  10. Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. Cancer. 2022 08 01; 128(15):2967-2977.
    View in: PubMed
    Score: 0.014
  11. Thoracoscopic Resection of Thoracic Inlet Neuroblastic Tumors in Young Children. J Laparoendosc Adv Surg Tech A. 2021 Dec; 31(12):1475-1479.
    View in: PubMed
    Score: 0.014
  12. Characteristics of benign neuroblastic tumors: Is surgery always necessary? J Pediatr Surg. 2022 Aug; 57(8):1538-1543.
    View in: PubMed
    Score: 0.013
  13. Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience. Pediatr Blood Cancer. 2021 09; 68(9):e29173.
    View in: PubMed
    Score: 0.013
  14. Blood product administration during high risk neuroblastoma therapy. Pediatr Hematol Oncol. 2020 Feb; 37(1):5-14.
    View in: PubMed
    Score: 0.012
  15. Evolving biopsy techniques for the diagnosis of neuroblastoma in children. J Pediatr Surg. 2018 Nov; 53(11):2235-2239.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.